Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Sentinel Lymph Node Biopsy × Clear all

NCT05981014 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms